International law firm Bird & Bird advised CurifyLabs on its $14 million Series A funding round, co-led by Sandwater and HealthCap, with participation from Tesi and existing investors.
CurifyLabs has developed a platform that automates the preparation of personalised medicines, combining proprietary software, GMP-manufactured inputs and 3D printing. The funding will be used to expand U.S. operations, strengthen supply chain infrastructure, enhance customer support, and accelerate product innovation.
The Bird & Bird team was led by partner Kimmo Reina and senior associate Miika Hiidenhovi.
